M E15 (Enalapril 2.5 mg)

Pill imprint M E15 has been identified as Enalapril maleate 2.5 mg.

Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; hypertensive emergency; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M E15

Enalapril maleate 2.5 mg M E15
Enalapril maleate 2.5 mg M E15
Enalapril maleate
Imprint:
M E15
Strength:
2.5 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1051
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
maleic acid
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0950 UDL Laboratories Inc
35356-0541 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)